CoChat

Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program

Open access
le Roux, Carel W., Zhang, Shuyu, Aronne, Louis J., Kushner, Robert F., Chao, Ariana M., Machineni, Sriram, Dunn, Julia, Chigutsa, Farai B., Ahmad, Nadia N., Bunck, Mathijs C. · 2023 · Obesity
Cited by 91

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Objective: Obesity is a growing global concern compounded by limited availability of effective treatment options. The SURMOUNT development program aims to evaluate the efficacy and safety of tirzepatide as an adjunct to lifestyle intervention compared with placebo on chronic weight management in adults with BMI ≥ 27 kg/m 2 with or without type 2 diabetes. Methods: The SURMOUNT program includes four global phase 3 trials NCT04184622 (SURMOUNT‐1), NCT04657003 (SURMOUNT‐2), NCT04657016 (SURMOUNT‐3), and NCT04660643 (SURMOUNT‐4). Participants are randomized to once‐weekly subcutaneous tirzepatide versus placebo in a double‐blind manner. The primary end point in all trials is the percentage change in body weight from randomization to end of treatment. Results for the primary end point for SURMOUNT‐1 were published recently and results for the other trials are expected in 2023. Results: Across trials, participants have a mean age of 44.9 to 54.2 years, are mostly female (50.7% to 69.7%), and have a mean BMI of 36.1 to 38.9. Conclusions: The extensive assessment of once‐weekly tirzepatide in the global SURMOUNT program will detail the clinical effects of this first‐in‐class glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist in chronic weight management.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/oby.23612

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 19

  1. 10.1038/oby.2008.231 · DOI · Paper page
  2. 10.1002/oby.20821 · DOI · Paper page
  3. 10.1038/oby.2000.32 · DOI · Paper page
  4. 10.1136/bmj.g2646 · DOI · Paper page
  5. 10.1111/obr.12783 · DOI · Paper page
  6. 10.1001/jama.2020.18977 · DOI
  7. 10.2337/dc21-1046 · DOI · Paper page
  8. 10.1111/dom.14235 · DOI
  9. 10.1016/j.soard.2015.11.027 · DOI · Paper page
  10. 10.1038/nrendo.2017.122 · DOI · Paper page
  11. 10.2337/dc20-S008 · DOI · Paper page
  12. 10.1136/jim-2021-001952 · DOI · Paper page
  13. 10.2337/dc19-S002 · DOI · Paper page
  14. 10.2337/diacare.28.6.1526 · DOI · Paper page
  15. 10.1001/jama.2018.14433 · DOI · Paper page
  16. Maruish ME, 2011, User's Manual for the SF‐36v2 Health Survey
  17. 10.1111/cob.12477 · DOI
  18. 10.1016/S0140-6736(21)01324-6 · DOI · Paper page
  19. 10.1016/S0140-6736(21)02188-7 · DOI · Paper page

Cited by

See all 91

Metadata

Authors
le Roux, C. W., Zhang, S., Aronne, L. J., Kushner, R. F., Chao, A. M., Machineni, S., Dunn, J., Chigutsa, F. B., Ahmad, N. N., & Bunck, M. C.
Venue
Obesity
Publisher
Wiley
Published
2022-12-07
Volume
31
Issue
1
Pages
96-110
ISSN
  • 1930-7381 (ISSN-L)
  • 1930-739X
OpenAlex
W4310940908
Cited by
91
References
23
FWCI
9.45
Type
journal article
Language
en
Open access
hybrid
Funders
Eli Lilly and Company

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.